Aimil Amyron Vet Syrup 500ml
“Highlights:
AMYRON Vet Syrup enhances the overall health performance of the animals.
Product Detail:
Amyron is a multi-ingredient formula for livestock enriched with Amla & Ashwagandha which contributes to exerting haematinic action & also prevents and overcomes the effect of stress, exerts adaptogenic action, and maintains body resistance, health & livability.
It also improves immunity in cattle to fight infections by Giloe, Shatavari & Musli and also improves milk production in dairy animals.
Rich in phytonutrients, minerals essential amino acids & vitamins for complementing nutritional requirements.
Ingredients and Nutritions:
Ashwagandha (Withania somnifera (L.) Dunal.),
Punernava (Boerhavia diffusa L.),
Bhringraj (Eclipta alba (L.) L.),
Draksh (Vitis vinifera L.),
Shatavar (Asparagus racemosus),
Kaunch (Mucuna pruriens (L.) DC),
Amla (Phyllanthus emblica L.),
Genhu / Wheat (Triticum aestivum),
Guduchi (Tinospora cardifolia (Willd.) Miers),
Varahi Kand (Dioscorea bulbifera),
Soyabean (Glycine max (L.) Merr.),
Manjistha (Rubia cordifolia L.),
Methi (Trigonella foenum-graecum L.),
Haritaki (Terminalia chebula Retz),
Shilajeet Sudh (Purified Black Bitumen),
Sariva / Anantmool (Hemidesmus indicus),
Surajmukhi (Helianthus annuus L. ),
Brahmi (Bacopa monnieri (L.) Wettst.),
Gokhru (Tribulus terrestis L),
Rajmash / Lobiya (Phaseolus vulgaris),
Singhara (Trapa natans),
Alsi (Linum usitatissimum Linn.),
Yashtimadhu (Glycyrrhiza glabra),
Pipal (Ficus religiosa),
Jaiphal (Myristica fragrant)
Features and Benefits:
Enhances water intake during various disease outbreaks.
Potent anti-stress & thus overcoming shifting/ transportation stress in cattle.
Being multi-ingredient / synergistic, Amyron Vet acts as an Anti-stress, adaptogenic, growth promotor, immunomodulator & haematinic/hemopoietic.
Feeding and User Guidelines:
Calves, Foals, Sheep, Goats, and pigs: 20 ml. twice a day.
Cattle and Horses: 25-30 ml twice a day.
Camel: 0.10 ml/kg body
Elephants: 50 ml twice a day.
Reviews
There are no reviews yet.